RCT

Welcome to the Brand page for “RCT”, which is offered here for Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; pharmaceutical preparations of engineered eythroid cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of a variety of human and animal diseases and conditions, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, none of the foregoing related chemical research, research services in connection with physics and engineering research, or to photovoltaic installations;.

Its status is currently believed to be active. Its class is unavailable. “RCT” is believed to be currently owned by “RUBIUS THERAPEUTICS, INC.”